CHEN Xiangyi, YU Dechen, ZHANG Ruihao, HU Yicun, WANG Keping, ZHOU Haiyu. Research progress on roles of Eph/Ephrin signaling pathway in primary bone tumor and bone cancer pain[J]. Journal of Clinical Medicine in Practice, 2021, 25(12): 128-132. DOI: 10.7619/jcmp.20211337
Citation: CHEN Xiangyi, YU Dechen, ZHANG Ruihao, HU Yicun, WANG Keping, ZHOU Haiyu. Research progress on roles of Eph/Ephrin signaling pathway in primary bone tumor and bone cancer pain[J]. Journal of Clinical Medicine in Practice, 2021, 25(12): 128-132. DOI: 10.7619/jcmp.20211337

Research progress on roles of Eph/Ephrin signaling pathway in primary bone tumor and bone cancer pain

  • Erythropoietin producing hepatocyte kinase (Eph) receptor and its ligand Ephrin play important roles in axon guidance, migration of neural progenitor cells and angiogenesis. The abnormal expressions of Eph and Ephrin are closely related to the occurrence, development, metastasis, prognosis and drug resistance of many tumors, and involve in many physiological and pathological processes, but the current research is still limited.This study mainly reviewed the roles of Eph and Ephrin in bone cancer pain (BCP) caused by primary and metastatic bone tumors.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return